On the public citation graph

Capillary Electrophoresis-Based Protein Kinase Ck2 Inhibitor Testing

0 signed · 18 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/elps.200900514openalex-extracted
A CE‐based assay for human protein kinase CK2 activity measurement and inhibitor screening
inferredcites →https://doi.org/10.1016/0006-2952(73)90196-2openalex-extracted
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
inferredcites →https://doi.org/10.1016/j.bmc.2013.08.013openalex-extracted
Discovery and characterization of synthetic 4′-hydroxyflavones—New CK2 inhibitors from flavone family
inferredcites →https://doi.org/10.1016/j.cell.2011.02.013openalex-extracted
Hallmarks of Cancer: The Next Generation
inferredcites →https://doi.org/10.1016/j.ejmech.2015.04.032openalex-extracted
Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening
inferredcites →https://doi.org/10.1016/j.ejmech.2020.112267openalex-extracted
A novel class of selective CK2 inhibitors targeting its open hinge conformation
inferredcites →https://doi.org/10.1016/j.it.2017.12.002openalex-extracted
Protein Kinase CK2: An Emerging Regulator of Immunity
inferredcites →https://doi.org/10.1016/j.phytochem.2016.12.018openalex-extracted
Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α′, the catalytic subunits of CK2
inferredcites →https://doi.org/10.1021/acsmedchemlett.5b00452openalex-extracted
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo
inferredcites →https://doi.org/10.1021/cb300610sopenalex-extracted
Kinase Drug Discovery – What’s Next in the Field?
inferredcites →https://doi.org/10.1021/jm101251qopenalex-extracted
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
inferredcites →https://doi.org/10.1023/a:1006882910351openalex-extracted
CK2, a protein kinase of the next millennium
inferredcites →https://doi.org/10.1038/mi.2012.57openalex-extracted
Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation
inferredcites →https://doi.org/10.1080/14756360600741834openalex-extracted
Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranones derivatives
inferredcites →https://doi.org/10.1126/sciadv.aau9060openalex-extracted
Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth
inferredcites →https://doi.org/10.1200/jco.2021.39.3_suppl.312openalex-extracted
Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.
inferredcites →https://doi.org/10.3390/ijms20184398openalex-extracted
Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
inferredcites →https://doi.org/10.3390/ph10010007openalex-extracted
CK2—An Emerging Target for Neurological and Psychiatric Disorders
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.